The Zhitong Finance App learned that Adarx Pharmaceuticals Inc. has applied for an IPO in the US to help fund the development of a series of pipeline drugs to treat various diseases by regulating gene expression.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.